{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:51:04Z","timestamp":1789408264520,"version":"build-2803163510"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016290","name":"Insamlingsstiftelsen Cancer- och Allergifonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The immune system plays a major role in recognizing and eliminating malignant cells, and this has been exploited in the development of immunotherapies aimed at either activating or reactivating the anti-tumor activity of a patient's immune system. A wide range of therapeutic approaches involving T lymphocytes, such as programmed cell death protein ligand-1 (PDL-1) inhibitors, cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) blockers, and CD19-targeted T-cell therapy through chimeric antigen receptor (CAR)-T cells or CD19\/CD3 bi-specific T-cell engagers, have been introduced to the field of oncology, leading to significant improvements in overall survival of adult cancer patients. During the past few years, the availability and approval of T-cell based immunotherapies have become a reality also for the treatment of childhood cancers. However, the distribution, ratio of regulatory to effector cells and the quality of T-cell responses early in life are distinct from those during adolescence and adulthood, raising the possibility that these differences impact the efficacy of immunotherapy. Herein we provide a brief overview of the properties of conventional T cell subsets during early life. Focusing on the most common cancer type during childhood, acute lymphoblastic leukemia (ALL), we describe how current conventional therapies used against ALL influence the T-cell compartment of small children. We describe early life T-cell responses in relation to immunotherapies engaging T-cell anticancer reactivity and present our opinion that it is not only immaturity of the adaptive immune system, but also the impact of an immunosuppressive environment that may prove disadvantageous in the setting of immunotherapies targeting pediatric cancer cells.<\/jats:p>","DOI":"10.3389\/fimmu.2021.582539","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T06:00:37Z","timestamp":1614837637000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["T Cell Subsets During Early Life and Their Implication in the Treatment of Childhood Acute Lymphoblastic Leukemia"],"prefix":"10.3389","volume":"12","author":[{"given":"Shanie","family":"Saghafian-Hedengren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Sverremark-Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/bmj.1.5022.779","article-title":"Cancer; a biological approach. I. The processes of control","volume":"1","author":"Burnet","year":"1957","journal-title":"Br Med J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.18632\/oncotarget.12739","article-title":"The concept of immune surveillance against tumors. The first theories","volume":"8","author":"Ribatti","year":"2017","journal-title":"Oncotarget"},{"key":"B3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O'Donnell","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T Cell Development, Localization, and Function throughout Life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-3083.2012.02671.x","article-title":"Paediatric reference values for the peripheral T cell compartment","volume":"75","author":"Schatorje","year":"2012","journal-title":"Scand J Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/sji.12474","article-title":"Percentiles of lymphocyte subsets in preterm infants according to gestational age compared to children and adolescents","volume":"84","author":"Huenecke","year":"2016","journal-title":"Scand J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/pr.2012.6","article-title":"Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values and diminished IL-7","volume":"71","author":"Correa-Rocha","year":"2012","journal-title":"Pediatr Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nri1292","article-title":"The many important facets of T-cell repertoire diversity","volume":"4","author":"Nikolich-Zugich","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev-immunol-091319-083608","article-title":"Neonatal T cells: a reinterpretation","volume":"38","author":"Rudd","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1002\/eji.200636976","article-title":"Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children","volume":"37","author":"Junge","year":"2007","journal-title":"Eur J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nm.4008","article-title":"Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues","volume":"22","author":"Thome","year":"2016","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1182\/blood-2002-11-3591","article-title":"Homeostatic control of T-cell generation in neonates","volume":"102","author":"Schonland","year":"2003","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0165-2478(97)00093-X","article-title":"IL-7 induces proliferation, variable cytokine-producing ability and IL-2 responsiveness in naive CD4+ T-cells from human cord blood","volume":"59","author":"Fukui","year":"1997","journal-title":"Immunol Lett"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3057::AID-IMMU3057>3.0.CO;2-Z","article-title":"IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells","volume":"28","author":"Hassan","year":"1998","journal-title":"Eur J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1182\/blood-2003-01-0232","article-title":"IL-15 drives neonatal T cells to acquire CD56 and become activated effector cells","volume":"102","author":"Cookson","year":"2003","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.4049\/jimmunol.167.4.1970","article-title":"Human recent thymic emigrants\u2013identification, expansion, and survival characteristics","volume":"167","author":"Hassan","year":"2001","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.4049\/jimmunol.161.11.5909","article-title":"IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire","volume":"161","author":"Soares","year":"1998","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1182\/blood-2004-03-0805","article-title":"Establishment of the CD4+ T-cell pool in healthy children and untreated children infected with HIV-1","volume":"104","author":"Hazenberg","year":"2004","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1172\/JCI112383","article-title":"Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies","volume":"77","author":"Wilson","year":"1986","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/nm.3670","article-title":"Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants","volume":"20","author":"Gibbons","year":"2014","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1074\/jbc.M609501200","article-title":"The human IL-13 locus in neonatal CD4+ T cells is refractory to the acquisition of a repressive chromatin architecture","volume":"282","author":"Webster","year":"2007","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.4049\/jimmunol.168.6.2820","article-title":"Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells","volume":"168","author":"White","year":"2002","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.celrep.2016.10.056","article-title":"CD8(+) T cells from human neonates are biased toward an innate immune response","volume":"17","author":"Galindo-Albarran","year":"2016","journal-title":"Cell Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1002\/eji.1830240832","article-title":"Decreased expression of the ligand for CD40 in newborn lymphocytes","volume":"24","author":"Fuleihan","year":"1994","journal-title":"Eur J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1002\/eji.1830240831","article-title":"Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn","volume":"24","author":"Brugnoni","year":"1994","journal-title":"Eur J Immunol"},{"key":"B27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4049\/jimmunol.156.1.119","article-title":"CD40 ligand is expressed and functional on activated neonatal T cells","volume":"156","author":"Splawski","year":"1996","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1097\/01.TP.0000084308.19565.2B","article-title":"Equivalent functional nuclear factor of activated T cell 1 mRNA and protein expression in cord blood and adult T cells. Transplantation","volume":"76","author":"O'Neill","year":"2003"},{"key":"B29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-3083.1985.tb01916.x","article-title":"The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study","volume":"22","author":"Steinmann","year":"1985","journal-title":"Scand J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1006\/cimm.1997.1148","article-title":"Phenotypic and immunohistological analyses of the human adult thymus: evidence for an active thymus during adult life","volume":"179","author":"Bertho","year":"1997","journal-title":"Cell Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S1074-7613(00)80056-4","article-title":"Generation of functional thymocytes in the human adult","volume":"10","author":"Jamieson","year":"1999","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0167-5699(96)80543-3","article-title":"Thymic involution with ageing: obsolescence or good housekeeping?","volume":"17","author":"George","year":"1996","journal-title":"Immunol Today"},{"key":"B33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-642-82480-7_2","article-title":"Changes in the human thymus during aging","volume":"75","author":"Steinmann","year":"1986","journal-title":"Curr Top Pathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"eaah6506","DOI":"10.1126\/sciimmunol.aah6506","article-title":"Longterm maintenance of human naive T cells through in situ homeostasis in lymphoid tissue sites","volume":"1","author":"Thome","year":"2016","journal-title":"Sci Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4049\/jimmunol.1800396","article-title":"Developmental regulation of effector and resident memory T cell generation during pediatric viral respiratory tract infection","volume":"201","author":"Connors","year":"2018","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature10434","article-title":"Peripheral education of the immune system by colonic commensal microbiota","volume":"478","author":"Lathrop","year":"2011","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1038\/s41467-018-05901-2","article-title":"Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis","volume":"9","author":"Sun","year":"2018","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/19490976.2015.1056973","article-title":"A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function","volume":"6","author":"Telesford","year":"2015","journal-title":"Gut Microbes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"17109","DOI":"10.1038\/s41598-019-53576-6","article-title":"Extracellular membrane vesicles from lactobacilli dampen IFN-gamma responses in a monocyte-dependent manner","volume":"9","author":"Mata Forsberg","year":"2019","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.exphem.2004.03.012","article-title":"CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene","volume":"32","author":"Takahata","year":"2004","journal-title":"Exp Hematol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jaci.2016.04.027","article-title":"FOXP3(+) CD4 T-cell maturity and responses to microbial stimulation alter with age and associate with early-life gut colonization","volume":"138","author":"Bjorkander","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"12163","DOI":"10.18632\/oncotarget.7512","article-title":"Human naive regulatory T-cells feature high steady-state turnover and are maintained by IL-7","volume":"7","author":"Silva","year":"2016","journal-title":"Oncotarget"},{"key":"B45","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1038\/cti.2015.2","article-title":"The ontogeny of naive and regulatory CD4(+) T-cell subsets during the first postnatal year: a cohort study","volume":"4","author":"Collier","year":"2015","journal-title":"Clin Transl Immunology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","article-title":"International incidence of childhood cancer, 2001-10: a population-based registry study","volume":"18","author":"Steliarova-Foucher","year":"2017","journal-title":"Lancet Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fped.2017.00248","article-title":"Targeting FLT3 signaling in childhood acute myeloid leukemia","volume":"5","author":"Sexauer","year":"2017","journal-title":"Front Pediatr"},{"key":"B49","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S2352-4642(18)30066-X","article-title":"Global efforts toward the cure of childhood acute lymphoblastic leukaemia","volume":"2","author":"Pui","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J Clin Oncol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3324\/haematol.2015.141101","article-title":"New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia","volume":"101","author":"Moorman","year":"2016","journal-title":"Haematologica"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1126\/science.1164266","article-title":"Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia","volume":"322","author":"Mullighan","year":"2008","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"11306","DOI":"10.1073\/pnas.1608420113","article-title":"Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia","volume":"113","author":"Oshima","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B54","doi-asserted-by":"publisher","first-page":"35445","DOI":"10.18632\/oncotarget.16367","article-title":"Pathogenesis of ETV6\/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"B55","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nrc2250","article-title":"Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy","volume":"7","author":"Colombo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/jclinpath-2016-203803","article-title":"Epstein-Barr virus and regulatory T cells in Egyptian paediatric patients with acute B lymphoblastic leukaemia","volume":"70","author":"Ateyah","year":"2017","journal-title":"J Clin Pathol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3892\/ol.2011.499","article-title":"Immunophenotype and increased presence of CD4(+)CD25(+) regulatory T cells in patients with acute lymphoblastic leukemia","volume":"3","author":"Wu","year":"2012","journal-title":"Oncol Lett"},{"key":"B58","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/08923973.2018.1424897","article-title":"Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia","volume":"40","author":"Salem","year":"2018","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10616-014-9828-7","article-title":"Autologous transplantation of CD34(+) bone marrow derived mononuclear cells in management of non-reconstructable critical lower limb ischemia","volume":"68","author":"Ismail","year":"2016","journal-title":"Cytotechnology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000351429","article-title":"High proportions of CD4(+) T cells among residual bone marrow T cells in childhood acute lymphoblastic leukemia are associated with favorable early responses","volume":"131","author":"Lustfeld","year":"2014","journal-title":"Acta Haematol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.blre.2017.08.009","article-title":"Insights into defective serological memory after acute lymphoblastic leukaemia treatment: the role of the plasma cell survival niche, memory B-cells and gut microbiota in vaccine responses","volume":"32","author":"Saghafian-Hedengren","year":"2018","journal-title":"Blood Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/08880019409141671","article-title":"Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia","volume":"11","author":"Alanko","year":"1994","journal-title":"Pediatr Hematol Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/pbc.20255","article-title":"Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group","volume":"44","author":"Ek","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1182\/blood-2005-03-1082","article-title":"Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia","volume":"106","author":"Haining","year":"2005","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.leukres.2005.05.024","article-title":"Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia","volume":"30","author":"Mazur","year":"2006","journal-title":"Leuk Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2141.2010.08478.x","article-title":"Immune reconstitution in children following chemotherapy for haematological malignancies: a long-term follow-up","volume":"152","author":"van Tilburg","year":"2011","journal-title":"Br J Haematol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.leukres.2010.10.005","article-title":"Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: impact on lymphocyte compartment composition","volume":"35","author":"van Tilburg","year":"2011","journal-title":"Leuk Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/pbc.26047","article-title":"Immunological reconstitution in children after completing conventional chemotherapy of acute lymphoblastic leukemia is marked by impaired B-cell compartment","volume":"63","author":"Koskenvuo","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"B69","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1158\/2159-8290.CD-18-1314","article-title":"Naive T-cell deficits at diagnosis and after chemotherapy impair cell therapy potential in pediatric cancers","volume":"9","author":"Das","year":"2019","journal-title":"Cancer Discov"},{"key":"B70","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1056\/NEJM199501193320303","article-title":"Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy","volume":"332","author":"Mackall","year":"1995","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1182\/blood.V89.10.3700","article-title":"Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy","volume":"89","author":"Mackall","year":"1997","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3389\/fimmu.2020.01341","article-title":"Evaluating thymic function after human hematopoietic stem cell transplantation in the personalized medicine era","volume":"11","author":"Gaballa","year":"2020","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fped.2020.00454","article-title":"Immune monitoring after allogeneic hematopoietic cell transplantation: toward practical guidelines and standardization","volume":"8","author":"Boelens","year":"2020","journal-title":"Front Pediatr"},{"key":"B74","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2018.01.006","article-title":"Thymopoiesis following HSCT; a retrospective review comparing interventions for aGVHD in a pediatric cohort","volume":"193","author":"Flinn","year":"2018","journal-title":"Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1182\/blood-2008-09-176594","article-title":"Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation","volume":"113","author":"Clave","year":"2009","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/cancers12071974","article-title":"Reconstitution of T Cell subsets following allogeneic hematopoietic cell transplantation","volume":"12","author":"Dekker","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1182\/hematology.2019000017","article-title":"Moving immunotherapy into the front line in ALL","volume":"2019","author":"Winters","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1200\/JCO.2016.67.3301","article-title":"Phase I\/Phase II study of blinatumomab in pediatric patients with relapsed\/refractory acute lymphoblastic leukemia","volume":"34","author":"von Stackelberg","year":"2016","journal-title":"J Clin Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-132435","article-title":"A randomized phase 3 trial of blinatumomab vs. chemotherapy as post-reinduction therapy in high and intermediate risk (HR\/IR) first relapse of B-Acute lymphoblastic leukemia (B-ALL) in children and adolescents\/young adults (AYAs) demonstrates superior efficacy and tolerability of blinatumomab: a report from children's oncology group study AALL1331","volume":"134","author":"Brown","year":"2019","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1182\/blood-2017-02-769208","article-title":"Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults","volume":"129","author":"Gardner","year":"2017","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.semcancer.2019.11.004","article-title":"Determinants of response and resistance to CAR T cell therapy","volume":"65","author":"Lesch","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40164-017-0074-5","article-title":"Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed\/refractory ALL","volume":"6","author":"Nagele","year":"2017","journal-title":"Exp Hematol Oncol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/leu.2017.41","article-title":"Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL","volume":"31","author":"Duell","year":"2017","journal-title":"Leukemia"},{"key":"B86","doi-asserted-by":"publisher","first-page":"76902","DOI":"10.18632\/oncotarget.12357","article-title":"T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80\/CD86 on leukemic blasts","volume":"7","author":"Feucht","year":"2016","journal-title":"Oncotarget"},{"key":"B87","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00281-017-0648-7","article-title":"Tissue compartmentalization of T cell responses during early life","volume":"39","author":"Zens","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1126\/science.1164511","article-title":"Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero","volume":"322","author":"Mold","year":"2008","journal-title":"Science"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3389\/fimmu.2018.01077","article-title":"Outgrowing the immaturity myth: the cost of defending from neonatal infectious disease","volume":"9","author":"Harbeson","year":"2018","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.immuni.2016.01.013","article-title":"Interleukin-35 limits anti-tumor immunity","volume":"44","author":"Turnis","year":"2016","journal-title":"Immunity"},{"key":"B91","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10(+) and IL-35(+) Treg cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.3892\/ol.2017.6034","article-title":"Epithelial-mesenchymal transition in cancer: role of the IL-8\/IL-8R axis","volume":"13","author":"Zhao","year":"2017","journal-title":"Oncol Lett"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.freeradbiomed.2004.03.023","article-title":"Regulation of T-cell apoptosis by reactive oxygen species","volume":"36","author":"Hildeman","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"320ra3","DOI":"10.1126\/scitranslmed.aad5222","article-title":"Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies","volume":"8","author":"Singh","year":"2016","journal-title":"Sci Transl Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e20191009","DOI":"10.1084\/jem.20191009","article-title":"Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells","volume":"217","author":"Tanaka","year":"2020","journal-title":"J Exp Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fimmu.2020.00888","article-title":"The advent of CAR T-Cell therapy for lymphoproliferative neoplasms: integrating research into clinical practice","volume":"11","author":"Cerrano","year":"2020","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nbt.4195","article-title":"Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo","volume":"36","author":"Rafiq","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4049\/jimmunol.1701155","article-title":"Chimeric antigen receptor T cell therapy: challenges to bench-to-bedside efficacy","volume":"200","author":"Srivastava","year":"2018","journal-title":"J Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e1150","DOI":"10.1002\/cti2.1150","article-title":"Deficits in the IgG(+) memory B-cell recovery after anthracycline treatment is confined to the spleen of rhesus macaques","volume":"9","author":"Lasaviciute","year":"2020","journal-title":"Clin Transl Immunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.582539\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T10:46:45Z","timestamp":1697971605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.582539\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":100,"alternative-id":["10.3389\/fimmu.2021.582539"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.582539","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"article-number":"582539"}}